• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体对反式激活具有细胞特异性和选择性作用。

A cell-specific and selective effect on transactivation by the androgen receptor.

作者信息

Gordon D A, Chamberlain N L, Flomerfelt F A, Miesfeld R L

机构信息

Department of Biochemistry, University of Arizona, Tucson 85721, USA.

出版信息

Exp Cell Res. 1995 Apr;217(2):368-77. doi: 10.1006/excr.1995.1099.

DOI:10.1006/excr.1995.1099
PMID:7698238
Abstract

The androgen (AR) and glucocorticoid receptors (GR) are related ligand-activated transcriptional regulators which bind the same cis-acting element and are coexpressed in a variety of cell types. Despite a shared DNA binding site, these receptors mediate diverse cellular responses. To explain this paradox, the existence of cell-specific factors that interact with, and modulate the function of, distinct receptors has been proposed. Prostate epithelial cell growth is sensitive to androgens, but is not affected by glucocorticoids, even though both AR and GR are expressed in these cells. We have recently isolated a unique panel of prostate epithelial cell lines from normal rats and have used these cell lines to examine cell-specific steroid responses. In this study, we compared the abilities of AR and GR to enhance transcription of several different reporter genes regulated by simple (i.e., noncompsite) hormone response elements (HREs) in prostate and nonprostate cell lines. The cell-specific effect occurred independently of the AR hormone binding domain and could be observed with a GAL4 fusion protein containing only the AR N-terminal regulatory domain. Gel shift analyses showed that the relative DNA binding affinity of AR for a probe containing a simple HRE was similar in prostate and nonprostate cell extracts. Presently, the only factors known to mediate steroid receptor-specific gene regulation are cJun and cFos, but there were no cell-specific differences in the functional levels of these proteins which could account for a preferential effect on AR-dependent transcription. Taken together, these results suggest that cell-specific activities exist which can preferentially modulate transcriptional transactivation by AR.

摘要

雄激素受体(AR)和糖皮质激素受体(GR)是相关的配体激活转录调节因子,它们结合相同的顺式作用元件,并在多种细胞类型中共同表达。尽管有共同的DNA结合位点,但这些受体介导不同的细胞反应。为了解释这一矛盾现象,有人提出存在与不同受体相互作用并调节其功能的细胞特异性因子。前列腺上皮细胞的生长对雄激素敏感,但不受糖皮质激素影响,尽管AR和GR在这些细胞中均有表达。我们最近从正常大鼠中分离出一组独特的前列腺上皮细胞系,并利用这些细胞系研究细胞特异性类固醇反应。在本研究中,我们比较了AR和GR增强前列腺和非前列腺细胞系中由简单(即非复合)激素反应元件(HRE)调控的几种不同报告基因转录的能力。细胞特异性效应独立于AR激素结合域发生,并且在仅含有AR N端调节域的GAL4融合蛋白中也能观察到。凝胶迁移分析表明,在前列腺和非前列腺细胞提取物中,AR对含有简单HRE的探针的相对DNA结合亲和力相似。目前,已知介导类固醇受体特异性基因调控的唯一因子是cJun和cFos,但这些蛋白质的功能水平在细胞间没有差异,无法解释对AR依赖性转录的优先效应。综上所述,这些结果表明存在细胞特异性活性,可优先调节AR的转录反式激活作用。

相似文献

1
A cell-specific and selective effect on transactivation by the androgen receptor.雄激素受体对反式激活具有细胞特异性和选择性作用。
Exp Cell Res. 1995 Apr;217(2):368-77. doi: 10.1006/excr.1995.1099.
2
Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.新型类固醇受体植物调节剂化合物A抑制前列腺癌细胞的生长和存活。
Cancer Res. 2008 Jun 15;68(12):4763-73. doi: 10.1158/0008-5472.CAN-07-6104.
3
Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.固醇调节元件结合蛋白-1c抑制雄激素受体的反式激活及前列腺细胞的雄激素依赖性生长。
Mol Cancer Res. 2008 Feb;6(2):314-24. doi: 10.1158/1541-7786.MCR-07-0354. Epub 2008 Feb 1.
4
Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.威尔姆斯肿瘤抑制基因WT1对雄激素信号通路的转录调控。
Anticancer Res. 2001 Jan-Feb;21(1A):1-10.
5
The androgen receptor (AR) amino-terminus imposes androgen-specific regulation of AR gene expression via an exonic enhancer.雄激素受体(AR)的氨基末端通过一个外显子增强子对AR基因表达进行雄激素特异性调控。
Endocrinology. 2001 Mar;142(3):1107-16. doi: 10.1210/endo.142.3.8049.
6
c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer.在前列腺癌中雄激素受体与Ets变异基因1之间新的相互作用中,c-Jun具有多种增强活性。
Mol Cancer Res. 2007 Jul;5(7):725-35. doi: 10.1158/1541-7786.MCR-06-0430.
7
Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.糖皮质激素处理后以及在不同细胞类型中,与糖皮质激素受体和c-jun启动子中AP-1位点结合的蛋白质的占有率和组成情况。
Recept Signal Transduct. 1996;6(3-4):179-93.
8
Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth.雄激素受体氨基末端肽的异位表达导致雄激素受体功能障碍并抑制雄激素受体介导的前列腺癌生长。
Mol Cell Endocrinol. 2004 Feb 12;214(1-2):175-87. doi: 10.1016/j.mce.2003.10.060.
9
c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.c-Jun增强雄激素受体反式激活与前列腺癌细胞增殖相关。
Oncogene. 2006 Nov 16;25(54):7212-23. doi: 10.1038/sj.onc.1209705. Epub 2006 May 29.
10
Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.雄激素受体非基因组信号的变化与LNCaP细胞向雄激素非依赖性的转变相关。
Cancer Res. 2004 Oct 1;64(19):7156-68. doi: 10.1158/0008-5472.CAN-04-1121.

引用本文的文献

1
Androgen regulation of the human FERM domain encoding gene EHM2 in a cell model of steroid-induced differentiation.类固醇诱导分化细胞模型中雄激素对人类FERM结构域编码基因EHM2的调控
Biochem Biophys Res Commun. 2003 Oct 17;310(2):421-32. doi: 10.1016/j.bbrc.2003.08.147.
2
Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus.雄激素受体N端新型共激活因子ART-27的鉴定与表征
Mol Biol Cell. 2002 Feb;13(2):670-82. doi: 10.1091/mbc.01-10-0513.